• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

• 페이스북 공유
• 트위터 공유
• 

ADHD Medication During Pregnancy and Breastfeeding

Women with ADHD face a difficult decision about whether to continue or stop taking ADHD medication during pregnancy and breastfeeding. There is a lack of information about how does adhd medication work for adults long-term exposure to these drugs can affect the fetus.

A study recently published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological disorders such as impaired hearing or vision, febrile seizures or IQ impairment. The authors acknowledge that more high-quality research is needed.

Risk/Benefit Analysis

Women who are pregnant and take adhd medication names medication need to evaluate the benefits of using it against the potential dangers for the foetus. Physicians do not have the information needed to make unequivocal recommendations however they can provide information about the risks and benefits to help pregnant women make informed choices.

A study published in Molecular Psychiatry found that women who were taking ADHD medications in early pregnancy did not have a significantly higher risk of fetal cardiac malformations or major structural birth defects. The researchers used a large population-based study of case-control to determine the prevalence of major structural birth defects in babies born to mothers who had taken stimulants during the early stages of pregnancy, and those who did not. Pediatric cardiologists, clinical geneticists and other experts examined the cases to confirm that the classification was correct and to eliminate any bias.

The research conducted by the researchers had some limitations. The most important issue was that they were unable to distinguish the effects of the medication from the effects of the disorder that is underlying. This limitation makes it difficult to know whether the small associations observed in the groups that were exposed result from medication use or comorbidities that cause confusion. Researchers also did not look at long-term outcomes for the offspring.

The study found that babies whose mothers had taken ADHD medication during pregnancy had a higher risk of admission to the neonatal care unit (NICU), compared to those whose mothers did not use any medication during pregnancy, or had stopped taking their medication before or during pregnancy. This was due to central nervous system disorders. The increased risk of admission was not influenced by the stimulant medications used during pregnancy.

Women who were taking stimulant starting adhd medication adults medications during pregnancy also had a higher likelihood of having an emergency caesarean section or having a baby that scored low on the Apgar scale (less than 7). These increases appear to be independent of the type of medication used during pregnancy.

The research suggests that the low risk associated with the use of ADHD medications during early pregnancy may be offset by the greater benefit to both mother and child from continued treatment for the woman's condition. Physicians should talk to their patients about this issue and try to help them develop coping strategies that could reduce the impact of her disorder in her daily life and relationships.

Medication Interactions

Doctors are increasingly confronted with the dilemma of whether to maintain treatment or stop as more women are diagnosed with ADHD. Most of the time, these decisions are taken in the absence of any evidence that is clear and definitive either way, so physicians have to weigh their experience from their own experiences, those of other doctors, and what the research says on the topic, along with their own judgments for each patient.

In particular, the issue of possible risks to the baby can be a challenge. A lot of studies on this subject are based on observations rather than controlled research and their findings are often contradictory. The majority of studies restrict their analysis to live births, which can underestimate the teratogenic impact leading to terminations or abortions of pregnancy. The study discussed in the journal club addresses these issues, by examining both information on deceased and live births.

The conclusion: While some studies have shown a positive association between ADHD medications and the possibility of certain birth defects, other studies have not found any evidence of a link, and most studies have a neutral or slight negative effect. In every case it is imperative to conduct a thorough analysis of the risks and benefits should be conducted.

It isn't easy, but not impossible for women with ADHD to stop taking their medication. In an article published in the Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can increase depression, feelings of loneliness and family conflict for those suffering from the disorder. Additionally, the loss of medication can interfere with the ability to complete job-related tasks and drive safely that are crucial aspects of a normal life for a lot of people with ADHD.

She recommends women who are unsure about whether or not to stop medication in light of their pregnancy, consider the possibility of educating friends, family members and colleagues about the condition, its effects on daily functioning, and on the benefits of keeping the current treatment plan. In addition, educating them can make the woman feel more comfortable when she is struggling with her decision. It is also worth noting that certain drugs can pass through the placenta so if a woman decides to stop her ADHD medication during pregnancy and breastfeeding, she must be aware that the effects of the drug could be transferred to the child.

Risk of Birth Defects

As the use and misuse of ADHD medication for odd and adhd to treat symptoms of attention deficit disorder hyperactivity disorder (ADHD), increases, so does concern about the potential adverse effects of the drugs on the fetuses. A study that was published in the journal Molecular Psychiatry adds to the body of knowledge on this subject. Using two massive data sets, researchers were able to look at more than 4.3 million pregnancies and see whether stimulant medications increased the risk of birth defects. While the overall risk remains low, the researchers discovered that the first-trimester exposure to ADHD medicines was associated with an increased risk of certain heart defects, like ventriculo-septal defects (VSD).

The researchers of the study found no association between early medication use and other congenital anomalies, like facial clefting, or club foot. The results are in line with previous studies revealing the presence of a small, but significant increase in the risk of developing cardiac malformations among women who began taking ADHD medications before the time of pregnancy. The risk increased in the latter part of pregnancy when a large number of women began to stop taking their medication.

Women who were taking ADHD medication during the first trimester were more likely to require a caesarean delivery, have a low Apgar after birth and had a baby that required help breathing at birth. The authors of the study were unable to eliminate bias due to selection because they limited the study to women with no other medical conditions that might have contributed to the findings.

Researchers hope their research will help doctors when they see pregnant women. They recommend that, while a discussion of risks and benefits is important but the decision to stop or maintain medication should be based on each woman's needs and the severity of her adhd medication without diagnosis uk symptoms.

The authors also caution that, while stopping the medication is an alternative, it is not an option to consider due to the high rate of depression and other mental health issues for women who are expecting or who are recently postpartum. Further, research shows that women who stop taking their medication will have a tough time adjusting to a life without them once the baby is born.

Nursing

It can be a challenge to become a mom. Women who suffer from ADHD who have to manage their symptoms while attending physician appointments, getting ready for the arrival of their child and adjusting to new household routines are often faced with a number of difficulties. Therefore, many women elect to continue taking their ADHD medications throughout the course of pregnancy.

The majority of stimulant medicines are absorbed by breast milk in small quantities, so the risk to breastfeeding infant is minimal. The amount of exposure to medications can vary depending upon the dosage, frequency of administration and the time of day. In addition, different medications are introduced into the baby's system via the gastrointestinal tract or breast milk. The impact of these medications on the health of a newborn isn't fully comprehended.

Because of the lack of research, some doctors may recommend stopping stimulant medication during the pregnancy of a woman. It is a difficult decision for the woman, who must weigh the advantages of her medication against the risks to the foetus. Until more information is available, doctors should inquire with all pregnant patients about their experience with ADHD and whether they are taking or planning to take medication during the perinatal period.

Numerous studies have proven that women can continue taking their ADHD medication safely while breastfeeding and during pregnancy. In response, a rising number of patients are opting to do so. They have concluded after consulting with their physicians that the benefits of retaining their current medication outweigh any possible risks.

It's important for women with ADHD who are contemplating breastfeeding to seek a specialist psychiatrist's guidance prior to becoming pregnant. They should discuss their medication with their doctor as well as the pros and cons of continuing treatment. This includes non-pharmacological strategies. Psychoeducation should also be provided to help pregnant people with ADHD understand their symptoms and the underlying disorder, learn about available treatments and to reinforce existing strategies for coping. This should include a multidisciplinary approach, which includes the GP doctors, obstetricians and psychiatrists. Pregnancy counseling should include a discussion of a treatment plan for the mother as well as the child, as well as monitoring for indicators of deterioration, and, if needed, adjustments to the medication regimen.